|
Samuel R. Schwartz, CPA, was appointed to the MedAvant Board of Directors in June 2006 and serves as the Chairman of the Audit Committee. He is Vice President, Controller and Chief Accounting Officer and a member of the Executive Management Operating Committee of Serologicals Corporation. Serologicals is a public life science/ biotech company with annual revenues in excess of $300 million, 1000 employees and operating facilities in North America, Europe and Asia. Mr. Schwartz has served in various senior financial management roles since joining Serologicals in 1998. Prior to joining Serologicals, he spent seven years as CEO/owner of a private manufacturing and distribution company and sixteen years in public accounting with Coopers & Lybrand, L.L.P., including five years as a audit partner. He has been a CPA since 1975. He has extensive experience in financial and management accounting, S.E.C. matters, mergers and acquisitions, capital formation, income taxation, as well as operating management experience in life sciences, manufacturing and service industries. Mr. Schwartz received his bachelor�s degree in Industrial Management from Georgia Tech and an MBA from Georgia State University. | 